Evolving Europe Principal Investments I (EEPI I) (Integral Venture Partners or Integral), a CEE-focused private equity and growth equity fund, invests in Medima Health (Medima), a chain of clinics with nationwide-network, specialized in imagining and radiology, alongside its current majority shareholder Morphosis Capital Fund I Cooperatief UA (Morphosis), a growth equity fund. The transaction comprises a cash injection to accelerate Medima’s network roll-out and a direct share purchase facilitating a partial exit for Morphosis.
About Medima Health
Medima Healthis a national network of medical imaging and radiology excellence clinics offering MRI/CT/PET-CT services. With nine modern operational clinics and ambitious development plans for Romania, Medima Health ensures patients access to high-performance imaging investigations, performed with modern technologies, at affordable prices and without long waiting lines. The Medima team comprises renowned radiologists, under the coordination of professor Dr. Gheorghe Iana, prominent Romanian radiologist and medical director of the network. In 2020, Medima Health partnered with the Romanian private equity fund, Morphosis Capital, for a nationwide expansion project.
About Integral Venture Partners
Integral Venture Partners manages institutional private equity and growth capital focused on investments in Central and South- Eastern Europe. Integral’s fund is backed by leading international institutional investors including the EIF, the EBRD, and the IFC. Integral covers its target markets out of hubs in London, Budapest, and Belgrade. At present, Integral’s portfolio investments include: Codecool, LuminoChem, Breaktime, Walter, Econic One, Ontotext and Borcad.
About Morphosis Capital
Morphosis Capital Fund I Cooperatief UA is a private equity fund with 50 million euro committed capital. Established in December 2018 by four Romanian entrepreneurs, Simona Gemeneanu, Gabriela Dumitru, Dragos Petre, and Andrei Gemeneanu, the fund aims to contribute to the development and transformation of Romanian SMEs. The European Investment Fund (EIF), the leading financing platform for European SMEs, co-financed through the Regional Operational Programme, is the anchor investor in Morphosis Capital. Banca Transilvania, international and local entrepreneurs, as well as the founders themselves, are the co-investors in the fund. Morphosis Capital invests between five to ten million euros in high-growth Romanian companies from sectors such as FMCG, niche healthcare, technology, and B2B services, which have a strong potential for international expansion and an EBITDA of a minimum of half a million euros. Morphosis Capital’s portfolio includes DocProcess, Medima Health, Dr Leahu Dental Clinics, EMI, Cronos Med and Stay Fit Gym.